After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

9th World One Health Congress in Lisbon

Last week we participated in the 9th World One Health Congress (9WOHC) in Lisbon, Portugal – a major global gathering dedicated to integrated human, animal, and environmental health approaches. Our

Read More

EXCO2019, the first and only global expo dedicated to the players active in the field of development cooperation

R-Evolution Worldwide Community Interest Company joined in EXCO2019, the first and only global expo dedicated to the innovative solutions provided by the actors of development cooperation: national and international agencies,

Read More

Soap bubbles against coronavirus in Uganda too !

The “Soap bubbles against coronavirus” initiative is sparking interest in other African nations as well. Indeed a group of young Ugandan decided to come together and create a group of

Read More